[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR20030066204A - A process for the preparation of an intermediate useful in the synthesis of cefditoren - Google Patents

A process for the preparation of an intermediate useful in the synthesis of cefditoren Download PDF

Info

Publication number
KR20030066204A
KR20030066204A KR1020020006540A KR20020006540A KR20030066204A KR 20030066204 A KR20030066204 A KR 20030066204A KR 1020020006540 A KR1020020006540 A KR 1020020006540A KR 20020006540 A KR20020006540 A KR 20020006540A KR 20030066204 A KR20030066204 A KR 20030066204A
Authority
KR
South Korea
Prior art keywords
formula
compound
amidase
penicillin
reaction
Prior art date
Application number
KR1020020006540A
Other languages
Korean (ko)
Inventor
이광혁
조성환
윤용식
박충실
임동권
Original Assignee
씨제이 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 씨제이 주식회사 filed Critical 씨제이 주식회사
Priority to KR1020020006540A priority Critical patent/KR20030066204A/en
Publication of KR20030066204A publication Critical patent/KR20030066204A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48Methylene radicals, substituted by hetero rings
    • C07D501/52Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by an araliphatic carboxylic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

PURPOSE: A process for the preparation of an intermediate useful in the synthesis of cefditoren is provided, thereby preparing the high quality cefditoren intermediate without using any organic solvent at room temperature. CONSTITUTION: A process for the preparation of 7 - amino - 3 - £2 - (4 - methylthiazol - 5 - yl) vinyl| - 3 - cephem carboxylic acid of the formula (I) as an intermediate useful in the synthesis of cefditoren comprises reacting 7 - phenylacetamido - 3 - £2 - (4 - methylthiazol - 5 - yl) vinyl| - 3 - cephem carboxylic acid of the formula (II) with penicillin G amidase to remove a phenylacet group at 7-site, wherein the reaction temperature is 5 to 40 deg. C and the reaction pH is 8 to 8.5; a filtration process of the immobilized penicillin G amidase is optionally added after the completion of the reaction; and a crystallization process by adding an organic solvent into the filtered solution to control pH of the solution is optionally added.

Description

세프디토렌 중간체의 제조방법{A PROCESS FOR THE PREPARATION OF AN INTERMEDIATE USEFUL IN THE SYNTHESIS OF CEFDITOREN}A process for producing ceftitorene intermediate {A PROCESS FOR THE PREPARATION OF AN INTERMEDIATE USEFUL IN THE SYNTHESIS OF CEFDITOREN}

본 발명은 구조식(I)의 7-아미노-3-[2-(4-메칠티아졸-5-일)-3-세펨 카르복실산의 제조방법에 관한 것으로서, 보다 구체적으로는 구조식(II)의 7-페닐아세트아미도-3-[2-(4-메칠티아졸-5-일)비닐]-3-세펨 카르복실산을 페니실린 G 아미다제와 반응시켜 구조식(I)의 7-아미노-3-[2-(4-메칠티아졸-5-일)-3-세펨 카르복실산을 제조하는 방법에 관한 것이다.The present invention relates to a method for preparing 7-amino-3- [2- (4-methylthiazol-5-yl) -3-cefe carboxylic acid of formula (I), and more specifically, formula (II) 7-phenylacetamido-3- [2- (4-methylthiazol-5-yl) vinyl] -3-cefem carboxylic acid of is reacted with penicillin G amidase to provide 7-amino- A method for preparing 3- [2- (4-methylthiazol-5-yl) -3-cefe carboxylic acid.

구조식(I)의 화합물은 제3세대 경구용 세파계 항생제인 구조식(V)의 세프디토렌 피복실(Cefditoren pivoxil)의 중요한 중간체로 사용될 수 있다.The compound of formula (I) can be used as an important intermediate of the ceftitorene pivoxil of formula (V), a third generation oral cephaic antibiotic.

구조식(V)의 세프디토렌은 통상 구조식(I)의 화합물의 7-아미노 위치에 구조식(IV)의 화합물을 반응시켜 제조할 수 있다:Ceftitorene of formula (V) can generally be prepared by reacting a compound of formula (IV) at the 7-amino position of a compound of formula (I):

식 중, R1은 통상적인 아미노그룹의 보호기로서 보호기가 없는 경우(수소)를 포함하며, X는 구조식(B)와의 반응에 의하여 쉽게 탈리되는 일반적인 그룹이다.Wherein R 1 is a protecting group of a common amino group, including a case where there is no protecting group (hydrogen), and X is a general group which is easily released by reaction with structural formula (B).

구조식(I)의 화합물을 제조하는 일반적 방법은 세펨 환의 7번 위치가 페닐아세틸로 보호되어 있는 구조인 구조식(III)의 화합물로부터 7번 위치의 아미노보호기인 페닐아세틸기를 오염화인/피리딘과 같은 강산에서 가수분해한 후, 4번 카르복실 기의 보호기인 R 그룹을 강산 촉매 하에서 탈보호하는 것이다.A general method for preparing the compound of formula (I) is a strong acid such as phosphorus / pyridine which is a phenylacetyl group which is an amino protecting group at position 7 from the compound of formula (III), in which the position 7 of the cefe ring is protected by phenylacetyl. After hydrolysis at, the R group which is a protecting group of the carboxyl group 4 is deprotected under a strong acid catalyst.

R = 다이페닐메칠 또는 p-메톡시벤질R = diphenylmethyl or p-methoxybenzyl

7번 위치의 아미노 보호그룹을 탈보호하기 위한 상기의 종래 방법은 일반적으로 반응이 격렬하여, -20도 정도의 저온에서 반응시키고, 오염화인/피리딘을 메칠렌클로라이드와 같은 용매조건에서 반응 종료점(약 1-2시간) 까지 반응시킨 후, 소량의 물을 첨가하고, 실온에서 추가로 교반한 후, 염기로 중화하여 생성된 산물을 물층으로 전환시킨다. 물층에 약간의 유기용매를 더 넣고 pH를 산성으로 조절하여 생성된 목적물을 수득한다.The conventional method for deprotecting the amino protecting group at position 7 is generally violent, and reacts at a low temperature of about -20 degrees, and reacts phosphorus / pyridine with solvent end point under solvent conditions such as methylene chloride. After about 1-2 hours), a small amount of water is added, further stirred at room temperature, and then neutralized with a base to convert the resulting product into a water layer. More organic solvent is added to the water layer and the pH is adjusted to acid to obtain the desired product.

이러한 종래 방법은, 반응 온도를 -20℃ 정도의 저온으로 유지시켜야하고, 또한 반응 부산물인 인산염이 물층에 존재하여, 역시 물층에 존재하는 구조식(I)의 목적 화합물의 수율 및 순도가 감소되는 등의 문제점이 있다.In this conventional method, the reaction temperature must be maintained at a low temperature of about -20 ° C, and the reaction by-product phosphate is present in the water layer, so that the yield and purity of the target compound of formula (I) also present in the water layer are reduced. There is a problem.

미국특허 제 5,441,874호에서는 세펨의 7-위치가 (2-아미노 -4-티아졸릴)아세틸 치환된 세펨 유도체의 합성중간체로서 7-아미도-[(2-N-페닐아세틸아미노 -4-티아졸릴)-2-아세틸]-3-아세톡시메틸-3-세펨-4-카르복실산을 페니실린 G 아미다제를 이용한 고정화 효소반응법으로 7-[(2-아미노- 티아졸릴-4-일)]아세트아미도 세팔로스포라닉 산을 제조하는 방법이 개시되어 있다.U.S. Pat.No. 5,441,874 discloses a 7-amido-[(2-N-phenylacetylamino-4-thiazolyl as a synthetic intermediate of the cefe derivative in which the 7-position of cefem is a (2-amino-4-thiazolyl) acetyl-substituted derivative. ) -2-acetyl] -3-acetoxymethyl-3-cepem-4-carboxylic acid by immobilized enzyme reaction with penicillin G amidase 7-[(2-amino-thiazolyl-4-yl)] A method for preparing acetamido cephalosporic acid is disclosed.

그러나, 세프디토렌 제조시 중요한 중간체인 구조식(I)의 화합물을 효소를 이용하여 제조하는 방법은 현재 공지된 바 없다.However, a method for preparing a compound of formula (I), which is an important intermediate in the preparation of ceftitorene, using an enzyme is not known at present.

이 점에 착안하여, 본 발명자들은 구조식(II)의 화합물을 페니실린 G 아미다제와 반응시켜 구조식(I)의 화합물을 제조할 경우, 보다 낮은 온도에서 안정적으로 반응을 수행할 수 있고, 고수율, 고순도로 구조식(I)의 화합물을 제조할 수 있음을 발견하고 본 발명을 완성하게 되었다.In view of this, the present inventors can stably react at a lower temperature when the compound of formula (II) is reacted with penicillin G amidase to prepare a compound of formula (I), It has been found that the compounds of formula (I) can be prepared in high purity and the present invention has been completed.

본 발명은 구조식(II)의 7-페닐아세트아미도-3-[2-(4-메칠티아졸-5-일)비닐]The invention provides 7-phenylacetamido-3- [2- (4-methylthiazol-5-yl) vinyl] of formula (II).

-3-세펨 카르복실산을 페니실린 G 아미다제와 반응시켜 7-위치의 페닐아세트기를 제거하는 단계를 포함하는 것을 특징으로 하는 구조식(I)의 7-아미노-3-[2-(4-메칠티아졸-5-일)비닐]-3-세펨 카르복실산을 제조하는 방법을 제공한다.Reacting 3-cefem carboxylic acid with penicillin G amidase to remove the phenylacet group at the 7-position, wherein 7-amino-3- [2- (4-methyl) Provided is a process for preparing thiazol-5-yl) vinyl] -3-cefe carboxylic acid.

본 발명에서 사용한 페니실린 G 아미다제는 고정화 담체의 종류에 관계없이 사용가능하며, 예를 들면 구형담체에 효소를 부착한, 로슈(Roche)사에서 시판하는 PGA-450를 사용한다. 페니실린 G 아미다제 고정화 효소는 반응 종류 후 여과시켜 재사용될 수 있다.The penicillin G amidase used in the present invention can be used irrespective of the type of immobilized carrier. For example, PGA-450 sold by Roche, which has an enzyme attached to a spherical carrier, is used. Penicillin G amidase immobilized enzyme can be reused by filtration after reaction type.

페니실린 G 아미다제를 사용하여 구조식(I)의 화합물을 제조하는 본 방법은 종래의 화학적인 제조 방법에서와 달리 유기 용매가 아닌 물 또는 무기염 완충용액에서 반응을 진행시킬 수 있다. 종래의 구조식(I) 화합물의 제조방법은 구조식(III)의 화합물을 유기 용매 내에서 저온에서(-20℃) 7-아미노 위치의 보호기를 탈보호시킨 후 4-카복시 위치의 보호기를 탈보호시켜 제조하였으나, 본 방법에서는 수용액 내에서 상온에서 구조식(II)의 화합물을 출발 물질로 사용할 수 있다.The present method for preparing the compound of formula (I) using penicillin G amidase can proceed the reaction in water or inorganic salt buffer, not an organic solvent, unlike in the conventional chemical preparation method. The conventional method for preparing the compound of formula (I) is to deprotect the compound of formula (III) at 7-amino position at low temperature (-20 ° C.) in an organic solvent and then deprotect the protecting group at the 4-carboxy position. However, in the present method, the compound of formula II may be used as a starting material at room temperature in aqueous solution.

구조식(II)의 화합물은 무기염 완충액을 넣고 염기로 pH를 조절하여 완전히 용해시킨다. 수층에 페니실린 G 아미다제를 넣고 5 ~ 40℃의 온도에서 무기염 용액을 이용하여 pH를 8.0~8.5로 유지하면서 단순 교반하여 반응시켜 구조식(I)의 화합물을 생성시킨다. 반응 종료 후 수층을 여과하여 페니실린 G 아미다제는 회수하고, 여액에는 적당한 유기용매를 넣고 pH를 산성으로 조절하여 구조식(I)의 목적 화합물을 재결정시켜 다량의 목적 화합물을 얻을 수 있다.The compound of formula II is completely dissolved by adding an inorganic salt buffer and adjusting the pH with a base. Penicillin G amidase was added to the aqueous layer and the mixture was reacted by simple stirring while maintaining the pH at 8.0 to 8.5 using an inorganic salt solution at a temperature of 5 to 40 ° C. to produce a compound of formula (I). After completion of the reaction, the aqueous layer was filtered to recover the penicillin G amidase, a suitable organic solvent was added to the filtrate, and the pH was adjusted to acid to recrystallize the target compound of formula (I) to obtain a large amount of the target compound.

구조식(II)의 화합물은 구조식(III)의 화합물에서 4-카복시기의 보호기를 탈보호시켜 제조할 수 있다. 탈보호 방법은 종래의 공지된 방법에 의한다. 구조식(III)의 화합물인 디페닐메칠 7-페닐아세트아미도-3-[2-(4-메칠티아졸-5-일)비닐]-3-세펨 카르복실레이트 및 p-메톡시벤질 7-페닐아세트아미도-3-[2-(4-메칠티아졸-5-일)비닐]-3-세펨 카르복실레이트는 공지의 제조방법에 의해 제조될 수 있는데, 예를 들면 미국 특허 제 4,918,068호와 미국 특허 제 6,288,223호에 상세히 기술되어 있다.Compounds of formula (II) may be prepared by deprotecting the protecting group of the 4-carboxy group in the compound of formula (III). The deprotection method is a conventionally known method. Diphenylmethyl 7-phenylacetamido-3- [2- (4-methylthiazol-5-yl) vinyl] -3-cepem carboxylate and p-methoxybenzyl 7- as compounds of formula (III) Phenylacetamido-3- [2- (4-methylthiazol-5-yl) vinyl] -3-cepem carboxylate can be prepared by known methods, for example US Pat. No. 4,918,068 And US Pat. No. 6,288,223.

본 발명은 구조식(II)의 7-페닐아세트아미도-3-[2-(4-메칠티아졸-5-일)비닐]The invention provides 7-phenylacetamido-3- [2- (4-methylthiazol-5-yl) vinyl] of formula (II).

-3-세펨 카르복실산을 페니실린 G 아미다제와 반응시켜 7-위치의 페닐아세트기를 제거시켜 제조한 구조식(I)의 7-아미노-3-[2-(4-메칠티아졸-5-일)비닐]-3-세펨 카르복실산을 구조식(IV)의 화합물과 반응시키는 단계를 포함하는 구조식(V)의 화합물을 제조하는 방법을 또한 제공한다.7-amino-3- [2- (4-methylthiazol-5-yl) of formula (I) prepared by reacting -3-cefem carboxylic acid with penicillin G amidase to remove the phenylacetyl group at the 7-position. Also provided is a method of preparing a compound of formula (V) comprising reacting a) vinyl] -3-cefe carboxylic acid with a compound of formula (IV).

이하, 본 발명의 구성과 작용을 실시예를 들어 상세히 설명한다. 본발명이 이들 실시예에 제한되는 것은 아니다.Hereinafter, the configuration and operation of the present invention will be described in detail by way of examples. The present invention is not limited to these examples.

참고예 1: 구조식(II)의 화합물의 제조Reference Example 1 Preparation of Compound of Structural Formula (II)

p-메톡시벤질 7-페닐아세트아미도-3-[2-(4-메칠티아졸-5-일)비닐]-3-세펨 카르복실레이트 40g(구조식(III)의 화합물)에 아니솔 200ml를 넣어 용해시킨 후,200 ml of anisole in 40 g of p-methoxybenzyl 7-phenylacetamido-3- [2- (4-methylthiazol-5-yl) vinyl] -3-cefe carboxylate (compound of formula (III)) After dissolving,

-15~-10℃로 냉각한다. 이 용액에 트리플로로아세틱산 160ml를 위 온도를 유지하며 천천히 넣는다. 적가가 완료되면 천천히 온도를 올려서 상온으로 한 후 이 온도에서 2시간동안 추가로 교반한다. TLC로 반응의 종료를 확인한다(전개용매: 아세토니트릴: 물 = 4 : 1). 반응액을 디이소프로필에테르에 상온에서 천천히 적가하여 고체를 생성시킨 후, 이 온도에서 1시간 교반한 후, 여과하고, 실온에서 진공건조하여 고체인 7-페닐아세틸아미도-3-[2-(4메칠티아졸-5-일)비닐]-3-세펨 카르복실산 (구조식(II)의 화합물) 28g을 얻었다.Cool down to -15 ~ -10 ℃. Into this solution, slowly add 160 ml of trifluoroacetic acid while maintaining the temperature above. When the dropping is completed, slowly raise the temperature to room temperature and stir at this temperature for 2 hours. TLC confirms the end of the reaction (developing solvent: acetonitrile: water = 4: 1). The reaction solution was slowly added dropwise to diisopropyl ether at room temperature to form a solid, which was then stirred at this temperature for 1 hour, filtered and dried under vacuum at room temperature to yield 7-phenylacetylamido-3- [2- as a solid. 28 g of (4methylthiazol-5-yl) vinyl] -3-cefe carboxylic acid (compound of formula (II)) were obtained.

1H NMR (CDCl3): 2.19 (3H, s), 3.18(1H, d, J=18Hz), 3.3(1H, d, J=18Hz), 1 H NMR (CDCl 3 ): 2.19 (3H, s), 3.18 (1H, d, J = 18 Hz), 3.3 (1H, d, J = 18 Hz),

3.62(2H, s), 5.05(1H, d, J=5Hz), 5.85(1H, m), 6.4(1H, d, J=12Hz), 6.6(1H, d, J=12Hz), 7.2~7.35(5H, m)3.62 (2H, s), 5.05 (1H, d, J = 5 Hz), 5.85 (1H, m), 6.4 (1H, d, J = 12 Hz), 6.6 (1H, d, J = 12 Hz), 7.2 to 7.35 (5H, m)

참고예 2: 구조식(II)의 화합물의 제조Reference Example 2: Preparation of Compound of Structural Formula (II)

디페닐메칠 7-페닐아세트아미도-3-[2-(4-메칠티아졸-5-일)비닐]-3-세펨 카르복실레이트 43.2g(구조식(III)의 화합물)을 아니솔 200ml를 넣어 용해시킨 후,200 ml of anisole 43.2 g of diphenylmethyl 7-phenylacetamido-3- [2- (4-methylthiazol-5-yl) vinyl] -3-cefem carboxylate (compound of formula (III)) After dissolution,

-15~-10℃로 냉각한다. 이 용액에 트리플로로아세틱산 160ml를 위 온도를 유지하며 천천히 넣는다. 적가가 완료되면 천천히 온도를 올려서 상온으로 한 후 이 온도에서 2시간동안 추가로 교반한다. TLC로 반응의 종료를 확인한다(전개용매: 아세토니트릴: 물 = 4 : 1).Cool down to -15 ~ -10 ℃. Into this solution, slowly add 160 ml of trifluoroacetic acid while maintaining the temperature above. When the dropping is completed, slowly raise the temperature to room temperature and stir at this temperature for 2 hours. TLC confirms the end of the reaction (developing solvent: acetonitrile: water = 4: 1).

반응액을 디이소프로필에테르에 상온에서 천천히 적가하여 고체를 생성시킨 후, 이 온도에서 1시간 교반한 후, 생성된 결정을 여과하여 얻은 고체는 7-페닐아세틸아미도-3-[2-(4메칠티아졸-5-일)비닐]-3-세펨 카르복실산(구조식(II)의 화합물)으로서 실온에서 진공건조하여 건체로 28.5g을 얻었다.The reaction solution was slowly added dropwise to diisopropyl ether at room temperature to form a solid. The mixture was stirred at this temperature for 1 hour, and the resulting crystal was filtered to give 7-phenylacetylamido-3- [2- ( 48.5 Methylthiazol-5-yl) vinyl] -3-cefe carboxylic acid (compound of formula (II)) was dried in vacuo at room temperature to give 28.5 g as a dry matter.

1H NMR (CDCl3): 2.19 (3H, s), 3.18(1H, d, J=18Hz), 3.3(1H, d, J=18Hz), 3.62(2H, s), 5.05(1H, d, J=5Hz), 5.85(1H, m), 6.4(1H, d, J=12Hz), 6.6(1H, d, J=12Hz), 7.2~7.35(5H, m) 1 H NMR (CDCl 3 ): 2.19 (3H, s), 3.18 (1H, d, J = 18 Hz), 3.3 (1H, d, J = 18 Hz), 3.62 (2H, s), 5.05 (1H, d, J = 5Hz), 5.85 (1H, m), 6.4 (1H, d, J = 12Hz), 6.6 (1H, d, J = 12Hz), 7.2 ~ 7.35 (5H, m)

실시예 1Example 1

7-페닐아세트아미도-3-[2-(4-메칠티아졸-5-일)비닐]-3-세펨 카르복실산 28g(28 g of 7-phenylacetamido-3- [2- (4-methylthiazol-5-yl) vinyl] -3-cefe carboxylic acid (

1.6mol)을 붕산 4g과 메칠렌클로라이드 200ml, 물 200ml를 넣고 교반하면서 10% 소디윰 카보네이트 수용액을 넣어 pH를 7.8~8.0으로 조절하여 용해시킨다. 실온에 정치하여 수층을 수득한다. 유기층은 물 50ml로 다시 재추출한다. 이렇게 얻은 수층을 합하여 페니실린 G 아미다제 1.44KU(10g, 습윤 중량)를 넣고 온도를 28~30℃로 높인다. 이 온도를 유지하면서 28% 암모니아수/ 물 = 1 : 1 혼합액을 넣어서 pH를 8.1~8.3을 유지한다. TLC(전개용매: 아세토니트릴: 물= 4 : 1)로 반응 종료를 확인한다.1.6 mol) is added to 4 g of boric acid, 200 ml of methylene chloride, and 200 ml of water, and a 10% sodium carbonate aqueous solution is added thereto while stirring to dissolve by adjusting the pH to 7.8-8.0. It is left at room temperature to obtain an aqueous layer. The organic layer is reextracted with 50 ml of water. The water layers thus obtained were combined and 1.44 KU (10 g, wet weight) of penicillin G amidase was added and the temperature was increased to 28-30 ° C. While maintaining this temperature, add a mixture of 28% ammonia water / water = 1: 1 to maintain the pH of 8.1 ~ 8.3. TLC (developing solvent: acetonitrile: water = 4: 1) confirms the completion of the reaction.

이 용액을 여과하여 고정화효소를 분리하여 물 20ml로 세척한다. 여액에는 아세톤 125ml를 넣고 12.5% 염산수용액으로 pH를 3.0으로 조절한 후 20~25℃에서 30분간 교반하여 결정을 생성시킨다. 생성된 고체를 여과하고, 아세톤 200ml로 세척하고, 35℃에서 진공건조하여 7-아미노-3-[2-(4-메칠티아졸-5-일)비닐]-3-세펨 카르복실 산 12.0g (수율 : 66%)을 얻었다.The solution is filtered to isolate immobilized enzyme and washed with 20 ml of water. 125 ml of acetone was added to the filtrate, and the pH was adjusted to 3.0 with 12.5% aqueous hydrochloric acid solution, followed by stirring at 20-25 ° C. for 30 minutes to form crystals. The resulting solid was filtered off, washed with 200 ml of acetone, and dried in vacuo at 35 ° C. to yield 12.0 g of 7-amino-3- [2- (4-methylthiazol-5-yl) vinyl] -3-cefe carboxylic acid. (Yield 66%) was obtained.

1H NMR (DMSO-d6): 2.38(3H, s), 3.31(1H, d, J=18Hz), 3.49(1H, d, J=18Hz), 4.84(1H, d, J=5Hz), 5.08(1H, d, J=5Hz), 6.37(1H, d, J=12Hz), 6.69(1H, d, J=12Hz), 8.91(1H, s) 1 H NMR (DMSO-d 6 ): 2.38 (3H, s), 3.31 (1H, d, J = 18 Hz), 3.49 (1H, d, J = 18 Hz), 4.84 (1H, d, J = 5 Hz), 5.08 (1H, d, J = 5 Hz), 6.37 (1H, d, J = 12 Hz), 6.69 (1H, d, J = 12 Hz), 8.91 (1H, s)

상기에서 상술한 바와 같이, 본발명은 7-아미노기가 보호된 구조식(II)의 화합물로부터 페니실린 G 아미다제를 이용하여 구조식(I)의 화합물을 제조하는 방법으로서, 유기용매을 사용하지 않고, 물을 용매로 사용하여 상온에서 반응시킬 수 있으며, 본 방법으로 수득한 생성물은 화학적인 방법으로 제조한 시료보다 색깔이 현저히 좋고, 부반응이 적게 진행되어 품질이 우수한 장점이 있다. 또한, 반응에 사용한 페니실린 G 아미다제 고정화효소는 여과 후 물로 세척하는 간단한 처리로 회수하여 계속 사용할 수 있는 장점이 있다.As described above, the present invention is a method for preparing a compound of formula (I) using penicillin G amidase from a compound of formula (II) in which a 7-amino group is protected, without using an organic solvent, It can be used as a solvent and can be reacted at room temperature, the product obtained by the present method is significantly better color than the sample prepared by the chemical method, there is an advantage that the quality of the side reaction is less progressed. In addition, the penicillin G amidase immobilized enzyme used in the reaction has the advantage that it can be recovered and used by a simple process of washing with water after filtration.

Claims (7)

구조식(II)의 7-페닐아세트아미도-3-[2-(4-메칠티아졸-5-일)비닐]-3-세펨 카르복실산을 페니실린 G 아미다제와 반응시켜 7-위치의 페닐아세트기를 제거하는 단계를 포함하는 것을 특징으로 하는 구조식(I)의 7-아미노-3-[2-(4-메칠티아졸-5-일)비닐]-3-세펨 카르복실산을 제조하는 방법.7-phenylacetamido-3- [2- (4-methylthiazol-5-yl) vinyl] -3-cefem carboxylic acid of formula II is reacted with penicillin G amidase to A process for preparing 7-amino-3- [2- (4-methylthiazol-5-yl) vinyl] -3-cefe carboxylic acid of formula (I), comprising removing the acet group. . 제 1항에 있어서, 구조식(II)의 화합물을 5 ~ 40℃의 온도 및 pH 8 ~ 8.5에서 페니실린 G 아미다제와 반응시키는 방법.The method of claim 1, wherein the compound of formula II is reacted with penicillin G amidase at a temperature of 5-40 ° C. and pH 8-8.5. 제 1항에 있어서, 구조식(II)의 화합물 1mol에 대하여 페니실린 G 아미다제를 5 x 10-3내지 1.5 x 10-1단위로 사용하는 방법.The process of claim 1 wherein penicillin G amidase is used in 5 × 10 −3 to 1.5 × 10 −1 units for 1 mol of compound of formula II. 제 2항에 있어서, 반응 종료 후 고정화 효소를 여과하고, 페니실린 G 아미다제를 회수하는 방법.The method according to claim 2, wherein the immobilized enzyme is filtered after completion of the reaction, and the penicillin G amidase is recovered. 제 3항에 있어서, 여과 후 얻어진 여액에 유기 용매를 넣어 pH를 산성으로 조절함으로써 구조식(I)의 화합물을 결정화시키는 단계를 추가로 포함하는 방법.4. The method of claim 3, further comprising crystallizing the compound of formula (I) by adding an organic solvent to the filtrate obtained after filtration to adjust the pH to acidic. 제 1항에 있어서, 구조식(II)의 화합물은 구조식(III)의 화합물에서 카복실기의 보호기인 R을 제거하여 얻어지는 방법.The method of claim 1, wherein the compound of formula (II) is obtained by removing R which is a protecting group of a carboxyl group in the compound of formula (III). [식 중, R은 디페닐메칠 또는 p-메톡시벤질임.]Wherein R is diphenylmethyl or p-methoxybenzyl. 제 1항의 방법에 따라 얻어진 구조식(I)의 화합물을 구조식(IV)의 화합물과반응시키는 단계를 포함하는 구조식(V)의 화합물을 제조하는 방법.A process for preparing a compound of formula (V) comprising the step of reacting a compound of formula (I) obtained according to the method of claim 1 with a compound of formula (IV). [식 중, R1은 H, 또는 통상적인 아미노그룹의 보호기이고, X는 구조식(B)와의 반응에 의하여 쉽게 탈리되는 일반적인 그룹임.[Wherein R 1 is a protecting group of H, or a common amino group, and X is a general group that is easily released by reaction with structural formula (B).
KR1020020006540A 2002-02-05 2002-02-05 A process for the preparation of an intermediate useful in the synthesis of cefditoren KR20030066204A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020020006540A KR20030066204A (en) 2002-02-05 2002-02-05 A process for the preparation of an intermediate useful in the synthesis of cefditoren

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020020006540A KR20030066204A (en) 2002-02-05 2002-02-05 A process for the preparation of an intermediate useful in the synthesis of cefditoren

Publications (1)

Publication Number Publication Date
KR20030066204A true KR20030066204A (en) 2003-08-09

Family

ID=32220575

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020020006540A KR20030066204A (en) 2002-02-05 2002-02-05 A process for the preparation of an intermediate useful in the synthesis of cefditoren

Country Status (1)

Country Link
KR (1) KR20030066204A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003141A3 (en) * 2003-07-04 2005-03-10 Orchid Chemicals & Pharm Ltd An improved process for the preparation of cefditoren
WO2007013043A2 (en) * 2005-07-29 2007-02-01 Ranbaxy Laboratories Limited Processes for the preparation of 7-amino-3-vinyl cephalosporanic acid

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839350A (en) * 1984-09-07 1989-06-13 Meiji Seika Kaisha, Ltd. Cephalosporin compounds and the production thereof
US4918068A (en) * 1986-03-03 1990-04-17 Meiji Seika Kaisha, Ltd. Cephem compounds
JPH02138188A (en) * 1988-11-17 1990-05-28 Dai Ichi Seiyaku Co Ltd Production of cephalosporin derivative
KR19980032015A (en) * 1996-12-19 1998-07-25 오쓰카유지로 Sephazoline Manufacturing Method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839350A (en) * 1984-09-07 1989-06-13 Meiji Seika Kaisha, Ltd. Cephalosporin compounds and the production thereof
US4918068A (en) * 1986-03-03 1990-04-17 Meiji Seika Kaisha, Ltd. Cephem compounds
JPH02138188A (en) * 1988-11-17 1990-05-28 Dai Ichi Seiyaku Co Ltd Production of cephalosporin derivative
KR19980032015A (en) * 1996-12-19 1998-07-25 오쓰카유지로 Sephazoline Manufacturing Method

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003141A3 (en) * 2003-07-04 2005-03-10 Orchid Chemicals & Pharm Ltd An improved process for the preparation of cefditoren
WO2007013043A2 (en) * 2005-07-29 2007-02-01 Ranbaxy Laboratories Limited Processes for the preparation of 7-amino-3-vinyl cephalosporanic acid
WO2007013043A3 (en) * 2005-07-29 2007-05-31 Ranbaxy Lab Ltd Processes for the preparation of 7-amino-3-vinyl cephalosporanic acid

Similar Documents

Publication Publication Date Title
JP3948628B2 (en) Method for producing cefdinir
US6388070B1 (en) Thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds
SK134399A3 (en) Cefdinir in the form of a salt with dicyclohexylamine, a process for its production and its use
EP0637587B1 (en) Bicyclic beta-lactam/paraben complexes
AU711228B2 (en) Production of cefotaxime and new sodium salts
JPH06172364A (en) Acylation of 7-amino group of cephalosporan
JP3751880B2 (en) Method for producing high-purity cefpodoxime proxetil
JP4022070B2 (en) Novel thiazole compound and method for producing the same
KR0177828B1 (en) Preparation of cephalosporin antibiotic using syn-isomer of thiazolyl intermediate
KR0178280B1 (en) Process for the preparation of a cephalosporin antibiotic
EP1220859B1 (en) Process for preparing 7-amino-3-methoxymethyl-3-cephem-4-carboxylic acid
KR20030066204A (en) A process for the preparation of an intermediate useful in the synthesis of cefditoren
KR100472048B1 (en) Novel method for producing Aztreonam
US7622577B2 (en) Processes for the preparation of cephalosporin derivatives
US7157574B2 (en) Process for preparing crystalline 3-chloromethyl-3-cephem derivatives
WO2005076694A2 (en) Improved process for the production of cefotaxime sodium
KR970004047B1 (en) Novel process for the preparation of cephem compound
KR20120078687A (en) Process for the preparation of cephalosporin intermediate using new enzyme
US20040002601A1 (en) Method for producing cephalosporins
KR100191120B1 (en) Process for the preparation of cephem derivatives
KR20110070523A (en) Process for the preparation of cephalosporin intermediate using new enzyme
KR960011779B1 (en) Novel process for preparing crystalline hydrate of cephalosporin
KR100512870B1 (en) Method for producing 7α-methoxycephalosporin derivative sodium salt 7-hydrate
KR100432425B1 (en) Novel method for preparation of cephem derivatives or salts thereof
KR20020011254A (en) Process for the preparation of cefuroxime

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application